129 related articles for article (PubMed ID: 9498736)
1. Partial agonistic action of clozapine at dopamine D2 receptors in dopamine depleted animals.
Ninan I; Kulkarni SK
Psychopharmacology (Berl); 1998 Feb; 135(3):311-7. PubMed ID: 9498736
[TBL] [Abstract][Full Text] [Related]
2. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
Jackson DM; Mohell N; Bengtsson A; Malmberg A
Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of olanzapine at dopamine D1 and D2 receptors in dopamine depleted animals.
Ninan I; Kulkarni SK
Psychopharmacology (Berl); 1999 Feb; 142(2):175-81. PubMed ID: 10102770
[TBL] [Abstract][Full Text] [Related]
4. The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Eur J Pharmacol; 1997 Apr; 324(1):31-7. PubMed ID: 9137910
[TBL] [Abstract][Full Text] [Related]
5. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
Zhou LW; Qin ZH; Weiss B
Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
[TBL] [Abstract][Full Text] [Related]
7. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
Starr BS; Starr MS; Kilpatrick IC
Neuroscience; 1987 Jul; 22(1):179-88. PubMed ID: 2957609
[TBL] [Abstract][Full Text] [Related]
8. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Bartoszyk GD; Harting J; Minck KO
J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of dopamine-dependent locomotion by clonidine in reserpine-treated mice is restricted to D2 agonists.
Starr MS; Starr BS
J Neural Transm Park Dis Dement Sect; 1994; 7(2):133-42. PubMed ID: 7710665
[TBL] [Abstract][Full Text] [Related]
10. Is clozapine an (partial) agonist at both dopamine D1 and D2 receptors?
Jackson DM; Wikström H; Liao Y
Psychopharmacology (Berl); 1998 Jul; 138(2):213-6. PubMed ID: 9718292
[No Abstract] [Full Text] [Related]
11. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
[TBL] [Abstract][Full Text] [Related]
12. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
[TBL] [Abstract][Full Text] [Related]
13. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.
Moody CA; Spear LP
Psychopharmacology (Berl); 1992; 107(1):39-49. PubMed ID: 1350350
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.
Starr MS; Starr BS
Psychopharmacology (Berl); 1994 Apr; 114(3):469-76. PubMed ID: 7855205
[TBL] [Abstract][Full Text] [Related]
16. Involvement of dopaminergic receptor subtypes in straub tail behaviour in mice.
Zarrindast MR; Bayat A; Shafaghi B
Gen Pharmacol; 1993 Jan; 24(1):127-30. PubMed ID: 8097737
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
Skuza G; Rogóz Z; Wieczorek A
Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
[TBL] [Abstract][Full Text] [Related]
18. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
Starr MS; Starr BS
Eur J Pharmacol; 1995 Apr; 277(2-3):151-8. PubMed ID: 7493603
[TBL] [Abstract][Full Text] [Related]
19. Similarity of clozapine and SCH 23390 in reserpinized rats suggests a common mechanism of action.
Chipkin RE; Latranyi MB
Eur J Pharmacol; 1987 Apr; 136(3):371-5. PubMed ID: 2886345
[TBL] [Abstract][Full Text] [Related]
20. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
